Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03403192 · ClinicalTrials.gov registry record · NA
EZ-blocker Versus Left Sided Double Lumen Tube in Adult Patients for Thoracic Surgery
A NA study of Thoracic Injuries, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 163
- Enrollment target
- 1
- Study location
NCT03403192 is a NA study of Thoracic Injuries that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 163 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03403192, a NA study of Thoracic Injuries, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 163 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to evaluate the positional stability and quality of lung isolation provided by the EZ-blocker compared to a DLT for both right and left sided thoracic surgery. An additional objective will be to assess time to placement of both devices and other significant clinical differences between these two approaches to placement of the bronchial blocker (BB) including airway injury and post-operatives sore throat, post-operative hoarseness, Additionally we would like to examine the preoperative high resolution CT imaging data to determine if there are anatomic landmarks that may potentially inform the appropriateness or inappropriateness of choosing an EZ-blocker or left sided DLT.
Conditions Studied
Interventions
- DEVICE EZ-Blocker
- DEVICE DLT
Study Locations (1)
North Carolina
- Wake Forest Baptist Hospital - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 163 participants |
| Start Date | 2018-01-26 |
| Est. Completion | 2019-10-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03403192
The ClinicalTrials.gov registry entry for NCT03403192 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 163 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Thoracic Injuries appearing as the primary indexed condition, and to 2 interventions - of which EZ-Blocker is the first listed.
NCT03403192 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT03403192 about?
NCT03403192 is a clinical study titled "EZ-blocker Versus Left Sided Double Lumen Tube in Adult Patients for Thoracic Surgery". The objective of this study is to evaluate the positional stability and quality of lung isolation provided by the EZ-blocker compared to a DLT for both right and left sided thoracic surgery. An additional objective will be to assess time to placement of both devices and other significant clinical d...
What is the current status of trial NCT03403192?
This trial is currently completed. It is a NA study. The enrollment target is 163 participants. The study started on 2018-01-26. Estimated completion is 2019-10-29.
What conditions does trial NCT03403192 study?
This clinical trial studies the following conditions: Thoracic Injuries.
What interventions are being tested in trial NCT03403192?
The interventions under investigation include: EZ-Blocker (DEVICE), DLT (DEVICE).
Who is sponsoring clinical trial NCT03403192?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03403192 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thoracic Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.